#842: The Story Behind EpiPen, The Rise of Food Allergies, and What Doctors Got Wrong
by
Get episode summaries just like this for all your favourite podcasts in your inbox every day!
Get More InsightsEpisode Summary
Unlock the full summary
Enter your email to read the complete summary, key takeaways and more.
Episode Summary
In this episode of The Tim Ferriss Show, Tim introduces an episode from a new podcast called Drug Story, hosted by Thomas Goetz. The episode explores the surprising rise of food allergies and the history of EpiPen, a device used for treating anaphylactic reactions. It highlights personal stories, especially that of Alex who lives with multiple food allergies, and covers the medical discoveries surrounding anaphylaxis and its treatment through epinephrine.
Goetz explains the development of EpiPen as a drug-device combination, where it administers epinephrine to counteract severe allergic reactions. He discusses the unintended consequences of medical advice from the late 20th century that recommended parents avoid introducing potentially allergenic foods to their children, a decision that contributed to the increase in food allergies rather than preventing them. Interviews with Dr. Gideon Lack reveal how introducing peanut products early can actually reduce the likelihood of allergies, showcasing the evolution of medical understanding.
The episode concludes by addressing the controversy surrounding the price increases of EpiPens, particularly after Mylan acquired the product in 2007, which drew public ire and scrutiny. Goetz emphasizes the ongoing challenges with food allergies and the therapeutic options now being explored to aid those already affected, hinting at future developments in the treatment of allergies.
Goetz explains the development of EpiPen as a drug-device combination, where it administers epinephrine to counteract severe allergic reactions. He discusses the unintended consequences of medical advice from the late 20th century that recommended parents avoid introducing potentially allergenic foods to their children, a decision that contributed to the increase in food allergies rather than preventing them. Interviews with Dr. Gideon Lack reveal how introducing peanut products early can actually reduce the likelihood of allergies, showcasing the evolution of medical understanding.
The episode concludes by addressing the controversy surrounding the price increases of EpiPens, particularly after Mylan acquired the product in 2007, which drew public ire and scrutiny. Goetz emphasizes the ongoing challenges with food allergies and the therapeutic options now being explored to aid those already affected, hinting at future developments in the treatment of allergies.
Key Takeaways
- Medical recommendations to delay exposure to allergens led to increased food allergies.
- Introducing potential allergens early in a child's diet can prevent allergies.
- The price of EpiPens skyrocketed after Mylan acquired it, resulting in public outrage.
Found an issue with this summary?
Log in to Report IssueMore Podcast Insights
The Running Channel Podcast
193: Is Running a Marathon Actually an Achievement Anymore?
Oct 24, 2026
This is Money Podcast
Inflation and the Budget - are things about to get better or worse?
Oct 23, 2026
Today in Focus
Who will be the next James Bond? – The Latest
Oct 23, 2026
Newscast
The Week Before The Secret Budget
Oct 23, 2026